Pillstats
Rx only · Syrup · Oral

Brompheniramine Maleate, Pseudoephedrine Hydrochloride, And Dextromethorphan Hydrobromide

Brompheniramine Maleate + Dextromethorphan Hydrobromide + Pseudoephedrine Hydrochloride

10 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US14 NDCs
10 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1767
US makers10 labelers
Packages26
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 12 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.023$0.046$0.069$0.092Dec 2025Mar 2026Jul 2026
$0.078
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
10
Active US suppliers
35%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

304K609K913K1.2M2025 Q12025 Q22025 Q32025 Q42026 Q1
813K
Rx · 2026 Q1
119.4M
Units dispensed
-23%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it10 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Acella Pharmaceuticals, LLCunknown5SUPPLYING
Bryant Ranch Prepackrepackager4SUPPLYING
REMEDYREPACK INC.repackager3SUPPLYING
Proficient Rx LPunknown3SUPPLYING
Chartwell RX, LLCunknown3SUPPLYING
Padagis US LLCunknown2SUPPLYING
Bionpharma Inc.unknown2SUPPLYING
Dr.Reddy's laboratories Limitedunknown2SUPPLYING
A-S Medication Solutionsunknown1SUPPLYING
Chartwell Governmental & Specialty RX, LLC.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.